E

Exact Therapeutics AS
OSE:EXTX

Watchlist Manager
Exact Therapeutics AS
OSE:EXTX
Watchlist
Price: 1.43 NOK 3.62% Market Closed
Market Cap: 90.5m NOK

Exact Therapeutics AS
Investor Relations

EXACT Therapeutics AS is a clinical stage biopharmaceutical company, which engages in the research and development of novel platform for ultrasound mediated therapeutic amplification. The company is headquartered in Oslo, Oslo and currently employs 8 full-time employees. The company went IPO on 2020-07-14. ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The firm's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. The company is done through harnessing the power of ultrasound in combination with ACT formulation.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Per Walday Ph.D.
Chief Executive Officer
No Bio Available
Dr. Masha Paule Nathalie Legris Stromme DPHIL
Vice-Chair of the Board
No Bio Available
Dr. Svein Kvåle
Co Founder & COO
No Bio Available
Mr. John M. Edminson
Chief Financial Officer
No Bio Available
Dr. Amir Snapir M.D., Ph.D.
Chief Medical Officer
No Bio Available
Mr. Caspar Foghsgaard
Chief Business Officer
No Bio Available
Dr. Per Christian Sontum
Founder
No Bio Available
Mr. Ragnar Bendicksen
Vice President of Technology
No Bio Available

Contacts

Address
OSLO
Oslo
Ostre Aker vei 19
Contacts